---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-004733"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:36:44.762950+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma issues 21.4M shares in Jan 2026 for $69,550, massive dilution

## Summary
- On Jan 15, 2026, issued 5,000,000 shares to satisfy $11,449 principal + $8,101 interest on convertible debt.
- On Jan 29, 2026, issued 5,302,732 shares to satisfy $12,000 principal + $1,000 interest.
- On Jan 30, 2026, issued 11,111,111 shares for $50,000 cash via Reg A offering.
- As of Feb 2, 2026, total shares outstanding: 129,468,577; implied average issuance price ~$0.003 per share.

## SEC filing metadata
- accession: 0001493152-26-004733
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000149315226004733/0001493152-26-004733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000149315226004733/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-004733
- JSON: https://secwatch.observer/filing/0001493152-26-004733.json
- Plain text: https://secwatch.observer/filing/0001493152-26-004733.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.